BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E; CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013;16:e1-e5. [PMID: 23538200 DOI: 10.1016/j.jval.2013.02.010] [Cited by in Crossref: 277] [Cited by in F6Publishing: 259] [Article Influence: 30.8] [Reference Citation Analysis]
Number Citing Articles
1 Etangsale A, Nunno L, Pineau J, Prognon P, Martelli N. Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review. Int J Technol Assess Health Care 2021;37:e79. [PMID: 34353388 DOI: 10.1017/S0266462321000532] [Reference Citation Analysis]
2 Faucett SC, Geisler BP, Chahla J, Krych AJ, Kurzweil PR, Garner AM, Liu S, LaPrade RF, Pietzsch JB. Meniscus Root Repair vs Meniscectomy or Nonoperative Management to Prevent Knee Osteoarthritis After Medial Meniscus Root Tears: Clinical and Economic Effectiveness. Am J Sports Med 2019;47:762-9. [PMID: 29517925 DOI: 10.1177/0363546518755754] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 16.5] [Reference Citation Analysis]
3 Zhou A, Yousem DM, Alvin MD. Cost-Effectiveness Analysis in Radiology: A Systematic Review. J Am Coll Radiol 2018;15:1536-46. [PMID: 30057243 DOI: 10.1016/j.jacr.2018.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
4 Schnippel K, Michelow P, Chibwesha CJ, Makura C, Lince-Deroche N, Goeieman B, Mulongo M, Jordaan S, Firnhaber C. Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis. BMC Health Serv Res 2015;15:499. [PMID: 26545585 DOI: 10.1186/s12913-015-1163-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ignatova D, Kamusheva M, Petrova G, Onchev G. Costs and outcomes for individuals with psychosis prior to hospital admission and following discharge in Bulgaria. Soc Psychiatry Psychiatr Epidemiol 2019;54:1353-62. [PMID: 30929041 DOI: 10.1007/s00127-019-01700-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Buendía JA, Patiño DG, Feliciano-Alfonso JE. Cost-utility of azithromycin in patients with severe asthma. J Asthma 2021;:1-8. [PMID: 34516322 DOI: 10.1080/02770903.2021.1980586] [Reference Citation Analysis]
7 Finkelstein EA, Krishnan A, Naheed A, Jehan I, de Silva HA, Gandhi M, Lim CW, Chakma N, Ediriweera DS, Khan J, Kasturiratne A, Hirani S, Solayman AKM, Jafar TH; COBRA-BPS study group. Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka. Lancet Glob Health 2021;9:e660-7. [PMID: 33751956 DOI: 10.1016/S2214-109X(21)00033-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value Health 2015;18:161-72. [PMID: 25773551 DOI: 10.1016/j.jval.2015.02.001] [Cited by in Crossref: 307] [Cited by in F6Publishing: 290] [Article Influence: 43.9] [Reference Citation Analysis]
9 Borisenko O, Lukyanov V, Ahmed AR. Cost-utility analysis of bariatric surgery. Br J Surg 2018;105:1328-37. [PMID: 29667178 DOI: 10.1002/bjs.10857] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
10 Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Health Technol Assess 2015;19:v-xxviii, 1-247. [PMID: 26173799 DOI: 10.3310/hta19510] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
11 Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S; EVAMICA study team. Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. Intensive Care Med 2017;43:1613-25. [PMID: 28374097 DOI: 10.1007/s00134-017-4766-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
12 Parackal A, Ramamoorthi K, Tarride JE. Economic Evaluation of Palliative Care Interventions: A Review of the Evolution of Methods From 2011 to 2019. Am J Hosp Palliat Care 2021;:10499091211011138. [PMID: 34024147 DOI: 10.1177/10499091211011138] [Reference Citation Analysis]
13 Cheng J, Zhang Y, Zhong A, Tian M, Zou G, Chen X, Yu H, Song F, Zhou S. Quality of Health Economic Evaluations in Mainland China: A Comparison of Peer-Reviewed Articles in Chinese and in English. Appl Health Econ Health Policy 2021. [PMID: 34322862 DOI: 10.1007/s40258-021-00674-0] [Reference Citation Analysis]
14 Yao J, Jiang X, You JHS. A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy. Inflamm Bowel Dis 2021;27:275-82. [PMID: 32311018 DOI: 10.1093/ibd/izaa073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Peterson C, Kearns MC. Systematic Review of Violence Prevention Economic Evaluations, 2000-2019. Am J Prev Med 2021;60:552-62. [PMID: 33608188 DOI: 10.1016/j.amepre.2020.11.002] [Reference Citation Analysis]
16 Ding D, Kolbe-Alexander T, Nguyen B, Katzmarzyk PT, Pratt M, Lawson KD. The economic burden of physical inactivity: a systematic review and critical appraisal. Br J Sports Med 2017;51:1392-409. [PMID: 28446455 DOI: 10.1136/bjsports-2016-097385] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
17 Park SK, Park JA, Yang SY, Shin JY, Koh H. The economic impact of disease progression and death in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data. Curr Med Res Opin 2020;36:1825-33. [PMID: 32965131 DOI: 10.1080/03007995.2020.1826917] [Reference Citation Analysis]
18 Buendía JA, Patiño DG. Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma. BMC Pulm Med 2021;21:398. [PMID: 34865635 DOI: 10.1186/s12890-021-01777-z] [Reference Citation Analysis]
19 Turner JP, Sanyal C, Martin P, Tannenbaum C, Newman AB. Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists. The Journals of Gerontology: Series A 2021;76:1061-7. [DOI: 10.1093/gerona/glaa180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster JY. Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective. Semin Arthritis Rheum 2020;50:394-400. [PMID: 32160943 DOI: 10.1016/j.semarthrit.2020.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Dreyfuss M, Giat Y, Veraguth D, Röösli C, Huber AM, Laske RD. Cost Effectiveness of Cochlear Implantation in Single-Sided Deafness. Otol Neurotol 2021;42:1129-35. [PMID: 34191788 DOI: 10.1097/MAO.0000000000003135] [Reference Citation Analysis]
22 Wang X, Guo G, Zheng J, Lu L. Programmes for the prevention of mother-to-child HIV infection transmission have made progress in Yunnan Province, China, from 2006 to 2015: a cost effective and cost-benefit evaluation. BMC Infect Dis 2019;19:64. [PMID: 30654744 DOI: 10.1186/s12879-019-3708-x] [Reference Citation Analysis]
23 Ollendorf DA, Pearson SD. Through the looking glass: making the design and output of economic models useful for setting medical policy. J Comp Eff Res 2014;3:53-61. [PMID: 24345257 DOI: 10.2217/cer.13.82] [Reference Citation Analysis]
24 Song M, Kanaoka H. Effectiveness of mobile application for menstrual management of working women in Japan: randomized controlled trial and medical economic evaluation. J Med Econ 2018;21:1131-8. [PMID: 30130990 DOI: 10.1080/13696998.2018.1515082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sanyal C, Turner JP, Martin P, Tannenbaum C. Cost‐Effectiveness of Pharmacist‐Led Deprescribing of NSAIDs in Community‐Dwelling Older Adults. J Am Geriatr Soc 2020;68:1090-7. [DOI: 10.1111/jgs.16388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Tan E, Gao L, Tran HN, Cadilhac D, Bladin C, Moodie M. Telestroke for acute ischaemic stroke: A systematic review of economic evaluations and a de novo cost-utility analysis for a middle income country. J Telemed Telecare 2021;:1357633X211032407. [PMID: 34292801 DOI: 10.1177/1357633X211032407] [Reference Citation Analysis]
27 Bergmeister KD, Große-Hartlage L, Daeschler SC, Rhodius P, Böcker A, Beyersdorff M, Kern AO, Kneser U, Harhaus L. Acute and long-term costs of 268 peripheral nerve injuries in the upper extremity. PLoS One 2020;15:e0229530. [PMID: 32251479 DOI: 10.1371/journal.pone.0229530] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
28 Duchesne L, Hejblum G, Njouom R, Touré Kane C, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa. PLoS One 2020;15:e0238035. [PMID: 32833976 DOI: 10.1371/journal.pone.0238035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
29 Hajjar A, Ergun MA, Alagoz O, Rampurwala M. Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer. PLoS One 2019;14:e0217778. [PMID: 31166995 DOI: 10.1371/journal.pone.0217778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
30 Baro E, Galperine T, Denies F, Lannoy D, Lenne X, Odou P, Guery B, Dervaux B. Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France. PLoS One 2017;12:e0170258. [PMID: 28103289 DOI: 10.1371/journal.pone.0170258] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
31 Caro JJ. What Is Insufficient about Validation? Med Decis Making 2015;35:817. [PMID: 26229082 DOI: 10.1177/0272989X15598743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Steinbeisser K, Schwarzkopf L, Graessel E, Seidl H. Cost-effectiveness of a non-pharmacological treatment vs. "care as usual" in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial. Eur J Health Econ 2020;21:825-44. [PMID: 32219623 DOI: 10.1007/s10198-020-01175-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Sussman M, Crivera C, Benner J, Adair N. Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review. Adv Ther 2021;38:4178-94. [PMID: 34251651 DOI: 10.1007/s12325-021-01841-4] [Reference Citation Analysis]
34 Chen YI, Barkun AN, Adam V, Bai G, Singh VK, Bukhari M, Gutierrez OB, Elmunzer BJ, Moran R, Fayad L, El Zein M, Kumbhari V, Repici A, Khashab MA. Cost-effectiveness analysis comparing lumen-apposing metal stents with plastic stents in the management of pancreatic walled-off necrosis. Gastrointest Endosc 2018; 88: 267-276. e1. [PMID: 29614262 DOI: 10.1016/j.gie.2018.03.021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
35 Cadilhac DA, Fisher R, Bernhardt J. How to do health services research in stroke: A focus on performance measurement and quality improvement. Int J Stroke 2018;13:166-74. [PMID: 29299958 DOI: 10.1177/1747493017750924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE; SPRINT Research Group. Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2017;377:745-55. [PMID: 28834469 DOI: 10.1056/NEJMsa1616035] [Cited by in Crossref: 76] [Cited by in F6Publishing: 42] [Article Influence: 15.2] [Reference Citation Analysis]
37 Capri S, Barbieri M, de Waure C, Boccalini S, Panatto D. Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population. Hum Vaccin Immunother 2018;14:1331-41. [PMID: 29425079 DOI: 10.1080/21645515.2018.1438792] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
38 Jiao B, Gulati R, Hendrix N, Gore JL, Rais-Bahrami S, Morgan TM, Etzioni R. Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United States. Value Health 2021;24:1111-7. [PMID: 34372976 DOI: 10.1016/j.jval.2021.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Denkinger CM, Schumacher SG, Gilpin C, Korobitsyn A, Wells WA, Pai M, Leeflang M, Steingart KR, Bulterys M, Schünemann H, Glaziou P, Weyer K. Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles. J Infect Dis 2019;220:S91-8. [PMID: 31593596 DOI: 10.1093/infdis/jiz097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
40 de Bont PAJM, van der Vleugel BM, van den Berg DPG, de Roos C, Lokkerbol J, Smit F, de Jongh A, van der Gaag M, van Minnen A. Health-economic benefits of treating trauma in psychosis. Eur J Psychotraumatol 2019;10:1565032. [PMID: 30719237 DOI: 10.1080/20008198.2018.1565032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jiao B, Basu A, Roth J, Bender M, Rovira I, Clemons T, Quach D, Ramsey S, Devine B. The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature. Pharmacoeconomics 2021. [PMID: 34368937 DOI: 10.1007/s40273-021-01072-z] [Reference Citation Analysis]
42 Kip MMA, IJzerman MJ, Henriksson M, Merlin T, Weinstein MC, Phelps CE, Kusters R, Koffijberg H. Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist. Med Decis Making 2018;38:778-88. [PMID: 30248275 DOI: 10.1177/0272989X18797590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
43 Lu P, Liang W, Li J, Hong Y, Chen Z, Liu T, Dong P, Huang H, Zhang T, Jiang J. A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma. Front Pharmacol 2020;11:619. [PMID: 32457618 DOI: 10.3389/fphar.2020.00619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Weber J, Angerer P, Brenner L, Brezinski J, Chrysanthou S, Erim Y, Feißt M, Hansmann M, Hondong S, Kessemeier FM, Kilian R, Klose C, Köllner V, Kohl F, Krisam R, Kröger C, Sander A, Schröder UB, Stegmann R, Wegewitz U, Gündel H, Rothermund E, Herrmann K. Early intervention, treatment and rehabilitation of employees with common mental disorders by using psychotherapeutic consultation at work: study protocol of a randomised controlled multicentre trial (friaa project). BMC Public Health 2021;21:1187. [PMID: 34158017 DOI: 10.1186/s12889-021-11195-9] [Reference Citation Analysis]
45 Wang J, Greuter MJW, Vermeulen KM, Brokken FB, Dorrius MD, Lu W, de Bock GH. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program. Breast 2021;61:58-65. [PMID: 34915447 DOI: 10.1016/j.breast.2021.12.004] [Reference Citation Analysis]
46 Klein NS, Wijnen BFM, Lokkerbol J, Buskens E, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H, Bockting CLH. Cost-effectiveness, cost-utility and the budget impact of antidepressants versus preventive cognitive therapy with or without tapering of antidepressants. BJPsych Open 2019;5:e12. [PMID: 30762507 DOI: 10.1192/bjo.2018.81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
47 Sadatsafavi M, FitzGerald JM, O'Byrne PM, Soliman M, Sriskandarajah N, Vicente C, Golam SM. The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada. Allergy Asthma Clin Immunol 2021;17:108. [PMID: 34641954 DOI: 10.1186/s13223-021-00610-w] [Reference Citation Analysis]
48 Shao T, Li X, Zhou C, Zang X, Malone DC, Zhang L, Zhou J, Tang W. Effectiveness and Efficiency of Non-drug Therapy Among Community-Dwelling Adults With Hypertension in China: A Protocol for Network Meta-Analysis and Cost-Effectiveness Analysis. Front Med (Lausanne) 2021;8:651559. [PMID: 33718415 DOI: 10.3389/fmed.2021.651559] [Reference Citation Analysis]
49 Brocklehurst P, Hoare Z, Woods C, Williams L, Brand A, Shen J, Breckons M, Ashley J, Jenkins A, Gough L, Preshaw P, Burton C, Shepherd K, Bhattarai N. Dental therapists compared with general dental practitioners for undertaking check-ups in low-risk patients: pilot RCT with realist evaluation. Health Serv Deliv Res 2021;9:1-118. [DOI: 10.3310/hsdr09030] [Reference Citation Analysis]
50 Poder TG. Challenges to make cost-effectiveness studies usable by decision makers. The Journal of Thoracic and Cardiovascular Surgery 2018;156:1931-2. [DOI: 10.1016/j.jtcvs.2018.05.062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
51 Wendelboe AM, Kim SE, Kinney S, Cuellar AE, Salinas L, Chou AF. Cost-Benefit Analysis of Allowing Additional Time in Cleaning Hospital Contact Precautions Rooms. Hosp Top 2021;99:130-9. [PMID: 33459211 DOI: 10.1080/00185868.2021.1873083] [Reference Citation Analysis]
52 Blankers M, Koppers D, Laurenssen EMP, Peen J, Smits ML, Luyten P, Busschbach J, Kamphuis JH, Kikkert M, Dekker JJM. Mentalization-Based Treatment Versus Specialist Treatment as Usual for Borderline Personality Disorder: Economic Evaluation Alongside a Randomized Controlled Trial With 36-Month Follow-Up. Journal of Personality Disorders 2021;35:373-92. [DOI: 10.1521/pedi_2019_33_454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
53 Nymark LS, Sharma T, Miller A, Enemark U, Griffiths UK. Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine 2017;35:6828-41. [PMID: 29146380 DOI: 10.1016/j.vaccine.2017.10.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
54 Pagès A, Porteils C, Labadens I, Parmier M, Oses S, Semely D, Bourdoncle M, Seigneuric B, Del Bello A, Juillard-Condat B. Cost-minimization analysis between intravenous iron sucrose and iron sucrose similar in hemodialysis patients. Expert Rev Pharmacoecon Outcomes Res 2020;20:281-7. [PMID: 31257944 DOI: 10.1080/14737167.2019.1632193] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Wang M, Liu J, Bellows BK, Qi Y, Sun J, Liu J, Moran AE, Zhao D. Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease. Glob Heart 2020;15:43. [PMID: 32923337 DOI: 10.5334/gh.830] [Reference Citation Analysis]
56 Zakiyah N, van Asselt ADI, Setiawan D, Cao Q, Roijmans F, Postma MJ. Cost-Effectiveness of Scaling Up Modern Family Planning Interventions in Low- and Middle-Income Countries: An Economic Modeling Analysis in Indonesia and Uganda. Appl Health Econ Health Policy 2019;17:65-76. [PMID: 30178267 DOI: 10.1007/s40258-018-0430-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Karpes Matusevich AR, Suarez‐almazor ME, Cantor SB, Lal LS, Swint JM, Lopez‐olivo MA. Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors. Arthritis Care Res 2020;72:343-52. [DOI: 10.1002/acr.23859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wesson HK, Boikhutso N, Hyder AA, Bertram M, Hofman KJ. Informing road traffic intervention choices in South Africa: the role of economic evaluations. Glob Health Action 2016;9:30728. [PMID: 27396485 DOI: 10.3402/gha.v9.30728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
59 Pagès A, Mazon M, Cool C, Mccambridge C, Cestac P, Rouch L, Juillard-condat B. Cost analysis of potentially inappropriate medication in older hospitalized patients. Expert Review of Pharmacoeconomics & Outcomes Research 2020;20:623-7. [DOI: 10.1080/14737167.2020.1678384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Hultgren R, Linné A, Svensjö S. Cost-effectiveness of targeted screening for abdominal aortic aneurysm in siblings. Br J Surg 2019;106:206-16. [PMID: 30702746 DOI: 10.1002/bjs.11047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
61 McCollister K, Yang X, Sayed B, French MT, Leff JA, Schackman BR. Monetary conversion factors for economic evaluations of substance use disorders. J Subst Abuse Treat 2017;81:25-34. [PMID: 28847452 DOI: 10.1016/j.jsat.2017.07.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
62 Carvalho N, Hoque ME, Oliver VL, Byrne A, Kermode M, Lambert P, McIntosh MP, Morgan A. Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings. BMC Med 2020;18:201. [PMID: 32718336 DOI: 10.1186/s12916-020-01658-y] [Reference Citation Analysis]
63 Gallagher J, Mccarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm 2014;36:1101-14. [DOI: 10.1007/s11096-014-0008-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
64 Akuze J, Annerstedt KS, Benova L, Chipeta E, Dossou JP, Gross MM, Kidanto H, Marchal B, Alvesson HM, Pembe AB, van Damme W, Waiswa P, Hanson C; ALERT Study Team. Action leveraging evidence to reduce perinatal mortality and morbidity (ALERT): study protocol for a stepped-wedge cluster-randomised trial in Benin, Malawi, Tanzania and Uganda. BMC Health Serv Res 2021;21:1324. [PMID: 34895216 DOI: 10.1186/s12913-021-07155-z] [Reference Citation Analysis]
65 Ledesma F, Buti M, Domínguez-Hernández R, Casado MA, Esteban R. Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence. Rev Esp Quimioter 2020;33:240-8. [PMID: 32510188 DOI: 10.37201/req/030.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Alshreef A, Jenks M, Green W, Dixon S. Review of Economic Submissions to NICE Medical Technologies Evaluation Programme. Appl Health Econ Health Policy 2016;14:623-34. [PMID: 27480537 DOI: 10.1007/s40258-016-0262-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Seleznova Y, Alayli A, Stock S, Müller D. Methodological issues in economic evaluations of disease prevention and health promotion: an overview of systematic and scoping reviews. BMC Public Health 2021;21:2130. [PMID: 34801013 DOI: 10.1186/s12889-021-12174-w] [Reference Citation Analysis]
68 Chen D, Kang P, Tao S, Li Q, Wang R, Tan Q. Cost-effectiveness evaluation of robotic-assisted thoracoscopic surgery versus open thoracotomy and video-assisted thoracoscopic surgery for operable non-small cell lung cancer. Lung Cancer 2021;153:99-107. [PMID: 33482409 DOI: 10.1016/j.lungcan.2020.12.033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Yong M, Wu YQ, Howlett J, Ballreich J, Walgama E, Thamboo A. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol 2021. [PMID: 34309219 DOI: 10.1002/alr.22865] [Reference Citation Analysis]
70 Zhou YF, Liu N, Wang P, Jeong Yang J, Song XY, Pan XF, Zhang X, He M, Li H, Gao YT, Xiang YB, Wu T, Yu D, Pan A. Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines. Hypertension 2020;76:750-8. [PMID: 32713271 DOI: 10.1161/HYPERTENSIONAHA.119.14533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
71 Huang HY, Liu CC, Yu Y, Wang L, Wu DW, Guo LW, Wang SH, Fang H, Bai Y, Fang Y, Fan Q, Sun C, Wu Y, Shi JF, Ma F, Tang Y, Dai M, Li N. Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review. Front Pharmacol 2020;11:572569. [PMID: 33536905 DOI: 10.3389/fphar.2020.572569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Dawson J, Howell M, Howard K, Campbell KL, Craig JC, Tong A, Lee VW. Cost-effectiveness of a mobile phone text messaging program (KIDNEYTEXT) targeting dietary behaviours in people receiving haemodialysis. J Hum Nutr Diet 2021. [PMID: 34323334 DOI: 10.1111/jhn.12937] [Reference Citation Analysis]
73 Jülicher P, Chulanov VP, Pimenov NN, Chirkova E, Yankina A, Galli C. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis. PLoS One 2019;14:e0219687. [PMID: 31310636 DOI: 10.1371/journal.pone.0219687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
74 DeRoos LJ, Marrero WJ, Tapper EB, Sonnenday CJ, Lavieri MS, Hutton DW, Parikh ND. Estimated Association Between Organ Availability and Presumed Consent in Solid Organ Transplant. JAMA Netw Open 2019;2:e1912431. [PMID: 31577360 DOI: 10.1001/jamanetworkopen.2019.12431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
75 van den Berg E, Schlochtermeier D, Koenders J, de Mooij L, Goudriaan A, Blankers M, Peen J, Dekker J. Implementing cognitive behavioral therapy-enhanced in a routine inpatient and outpatient setting: Comparing effectiveness and treatment costs in two consecutive cohorts. Int J Eat Disord 2020;53:461-71. [PMID: 31998992 DOI: 10.1002/eat.23229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Kim SY, Min KD, Jung SM, Russell LB, Toscano C, Minamisava R, Andrade ALS, Sanderson C, Sinha A. Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries. Vaccine 2021;39:147-57. [PMID: 33303182 DOI: 10.1016/j.vaccine.2020.09.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
77 Mendez LC, Moraes FY, Castilho MS, Louie AV, Qu XM. Lives and Economic Loss in Brazil due to Lack of Radiotherapy Access in Cervical Cancer: A Cost-Effectiveness Analysis. Clin Oncol (R Coll Radiol) 2019;31:e143-8. [PMID: 31160129 DOI: 10.1016/j.clon.2019.05.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Sørensen CA, de Thurah A, Lisby M, Olesen C, Sørensen SB, Enemark U. Cost-consequence analysis of self-administration of medication during hospitalization: a pragmatic randomized controlled trial in a Danish hospital setting. Ther Adv Drug Saf 2020;11:2042098620929921. [PMID: 32922722 DOI: 10.1177/2042098620929921] [Reference Citation Analysis]
79 Geisler BP, Ji YD, Peacock ZS. Value in Oral and Maxillofacial Surgery: A Systematic Review of Economic Analyses. Journal of Oral and Maxillofacial Surgery 2017;75:2287-303. [DOI: 10.1016/j.joms.2017.05.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
80 Nuckols TK, Needleman J, Grogan TR, Liang L, Worobel-luk P, Anderson L, Czypinski L, Coles C, Walsh CM. Clinical Effectiveness and Cost of a Hospital-Based Fall Prevention Intervention: The Importance of Time Nurses Spend on the Front Line of Implementation. JONA: The Journal of Nursing Administration 2017;47:571-80. [DOI: 10.1097/nna.0000000000000545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
81 You X, Gu J, Xu DR, Huang S, Xue H, Hao C, Ruan Y, Sylvia S, Liao J, Cai Y, Peng L, Wang X, Li R, Li J, Hao Y. Impact of the gate-keeping policies of China's primary healthcare model on the future burden of tuberculosis in China: a protocol for a mathematical modelling study. BMJ Open 2021;11:e048449. [PMID: 34433597 DOI: 10.1136/bmjopen-2020-048449] [Reference Citation Analysis]
82 Jiang Y, Cai D, Shi S. Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study. Infect Dis Model 2022;7:109-21. [PMID: 34909514 DOI: 10.1016/j.idm.2021.12.002] [Reference Citation Analysis]
83 Khoshbin A, Haddad FS, Ward S, O hEireamhoin S, Wu J, Nherera L, Atrey A. A cost-effectiveness assessment of dual-mobility bearings in revision hip arthroplasty. Bone Joint J 2020;102-B:1128-35. [PMID: 32862681 DOI: 10.1302/0301-620X.102B9.BJJ-2019-1742.R1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
84 Barker AK, Scaria E, Safdar N, Alagoz O. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection. JAMA Netw Open 2020;3:e2012522. [PMID: 32789514 DOI: 10.1001/jamanetworkopen.2020.12522] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
85 Ruiz-negrón N, Menon J, King JB, Ma J, Bellows BK. Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. PharmacoEconomics 2019;37:669-88. [DOI: 10.1007/s40273-018-00761-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
86 Santatiwongchai B, Chantarastapornchit V, Wilkinson T, Thiboonboon K, Rattanavipapong W, Walker DG, Chalkidou K, Teerawattananon Y. Methodological variation in economic evaluations conducted in low- and middle-income countries: information for reference case development. PLoS One 2015;10:e0123853. [PMID: 25950443 DOI: 10.1371/journal.pone.0123853] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
87 Willis SR, van der Meulen J, Valerio M, Miners A, Ahmed HU, Emberton M. A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer. Current Opinion in Urology 2015;25:483-9. [DOI: 10.1097/mou.0000000000000220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
88 Carvalho N, Jit M, Cox S, Yoong J, Hutubessy RCW. Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. Pharmacoeconomics 2018;36:79-90. [PMID: 28905279 DOI: 10.1007/s40273-017-0569-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
89 Al-Badriyeh D, Alameri M, Al-Okka R. Cost-effectiveness research in cancer therapy: a systematic review of literature trends, methods and the influence of funding. BMJ Open 2017;7:e012648. [PMID: 28131999 DOI: 10.1136/bmjopen-2016-012648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
90 Angehrn Z, Sostar J, Nordon C, Turner A, Gove D, Karcher H, Keenan A, Mittelstadt B, de Reydet-de Vulpillieres F. Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review. J Alzheimers Dis 2020;76:923-40. [PMID: 32597799 DOI: 10.3233/JAD-191159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Fuentes S, Núñez-Alfonsel J, Pradillos-Serna JM, Grande-Moreillo C, Margarit-Mallol J, Valladares-Díez S, Ardela-Díaz E. Quality of Life in Pediatric Minimally Invasive Surgery. Cost-Utility Analysis of Laparoscopic Versus Open Appendectomy. J Laparoendosc Adv Surg Tech A 2021. [PMID: 34534010 DOI: 10.1089/lap.2021.0495] [Reference Citation Analysis]
92 Brandão SMG, Rezende PC, Rocca HB, Ju YT, de Lima ACP, Takiuti ME, Hueb W, Bocchi EA. Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial. Cost Eff Resour Alloc 2018;16:55. [PMID: 30410425 DOI: 10.1186/s12962-018-0158-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Spin P, Sketris I, Hill-Taylor B, Ward C, Hurley KF. A Cost Analysis of Salbutamol Administration by Metered-Dose Inhalers with Spacers versus Nebulization for Patients with Wheeze in the Pediatric Emergency Department: Evidence from Observational Data in Nova Scotia. CJEM 2017;19:1-8. [PMID: 27506243 DOI: 10.1017/cem.2016.344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
94 Hopkins TJ, Eggington S, Quinn M, Nichols-Ricker CI. Cost-effectiveness of balloon kyphoplasty and vertebroplasty versus conservative medical management in the USA. Osteoporos Int 2020;31:2461-71. [PMID: 32656632 DOI: 10.1007/s00198-020-05513-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Wong WWL, Zargar M, Berry SR, Ko YJ, Riesco-Martínez M, Chan KKW. Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer. Curr Oncol 2019;26:e597-609. [PMID: 31708653 DOI: 10.3747/co.26.4843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Hayward KS, Kramer SF, Thijs V, Ratcliffe J, Ward NS, Churilov L, Jolliffe L, Corbett D, Cloud G, Kaffenberger T, Brodtmann A, Bernhardt J, Lannin NA. A systematic review protocol of timing, efficacy and cost effectiveness of upper limb therapy for motor recovery post-stroke. Syst Rev 2019;8:187. [PMID: 31345263 DOI: 10.1186/s13643-019-1093-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
97 Giusepi I, John AS, Jülicher P. Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review. The Journal of Applied Laboratory Medicine 2020;5:954-66. [DOI: 10.1093/jalm/jfaa107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Criss SD, Mooradian MJ, Watson TR, Gainor JF, Reynolds KL, Kong CY. Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States. JAMA Netw Open 2019;2:e1911952. [PMID: 31553470 DOI: 10.1001/jamanetworkopen.2019.11952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
99 Luchristt D, Geynisman-Tan J, Mueller MG, Kenton K. Cost-effectiveness Analysis of Universal Cystoscopy at the Time of Benign Laparoscopic Hysterectomy. J Minim Invasive Gynecol 2021;28:1470-83. [PMID: 33310171 DOI: 10.1016/j.jmig.2020.12.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Jülicher P, Varounis C. Estimating the cost-effectiveness of screening a general population for cardiovascular risk with high-sensitivity troponin-I. Eur Heart J Qual Care Clin Outcomes 2021:qcab005. [PMID: 33502472 DOI: 10.1093/ehjqcco/qcab005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 van Waardhuizen CN, Langhout M, Ly F, Braun L, Genders TSS, Petersen SE, Fleischmann KE, Nieman K, Hunink MGM. Diagnostic Performance and Comparative Cost-Effectiveness of Non-invasive Imaging Tests in Patients Presenting with Chronic Stable Chest Pain with Suspected Coronary Artery Disease: A Systematic Overview. Curr Cardiol Rep 2014;16. [DOI: 10.1007/s11886-014-0537-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
102 Cronin P, Rawson JV. Review of Research Reporting Guidelines for Radiology Researchers. Academic Radiology 2016;23:537-58. [DOI: 10.1016/j.acra.2016.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
103 Betancourt AS, Milagros GC, Sibaja P, Fernandez L, Norwood S. Cost evaluation of temporary abdominal closure methods in abdominal sepsis patients successfully treated with an open abdomen. Should we take temporary abdominal closure methods at face value? Health economic evaluation. Ann Med Surg (Lond) 2020;56:11-6. [PMID: 32566220 DOI: 10.1016/j.amsu.2020.06.007] [Reference Citation Analysis]
104 Lee YY, Barendregt JJ, Stockings EA, Ferrari AJ, Whiteford HA, Patton GA, Mihalopoulos C. The population cost-effectiveness of delivering universal and indicated school-based interventions to prevent the onset of major depression among youth in Australia. Epidemiol Psychiatr Sci 2017;26:545-64. [PMID: 27509769 DOI: 10.1017/S2045796016000469] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
105 Brodszky V, Beretzky Z, Baji P, Rencz F, Péntek M, Rotar A, Tachkov K, Mayer S, Simon J, Niewada M, Hren R, Gulácsi L. Cost-of-illness studies in nine Central and Eastern European countries. Eur J Health Econ 2019;20:155-72. [PMID: 31104219 DOI: 10.1007/s10198-019-01066-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
106 Clément V, Raimond V. Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs. Value Health 2019;22:220-4. [PMID: 30711067 DOI: 10.1016/j.jval.2018.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Anderson M, Davidson T, Dahllöf G, Grindefjord M. Economic evaluation of an expanded caries-preventive program targeting toddlers in high-risk areas in Sweden. Acta Odontologica Scandinavica 2019;77:303-9. [DOI: 10.1080/00016357.2018.1548709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Costa ML, Achten J, Hennings S, Boota N, Griffin J, Petrou S, Maredza M, Dritsaki M, Wood T, Masters J, Pallister I, Lamb SE, Parsons NR. Intramedullary nail fixation versus locking plate fixation for adults with a fracture of the distal tibia: the UK FixDT RCT. Health Technol Assess 2018;22:1-148. [PMID: 29785926 DOI: 10.3310/hta22250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
109 Grochtdreis T, König HH, Dobruschkin A, von Amsberg G, Dams J. Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review. PLoS One 2018;13:e0208063. [PMID: 30517165 DOI: 10.1371/journal.pone.0208063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
110 Duval S, Long KH, Roy SS, Oldenburg NC, Harr K, Fee RM, Sharma RR, Alesci NL, Hirsch AT. The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease. Journal of the American College of Cardiology 2015;66:1566-74. [DOI: 10.1016/j.jacc.2015.06.1349] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
111 Yang F, Liao M, Wang P, Yang Z, Liu Y. The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations. Appl Health Econ Health Policy 2021;19:163-80. [PMID: 33047212 DOI: 10.1007/s40258-020-00614-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Buendía JA, Patiño DG. Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma. BMC Pulm Med 2021;21:397. [PMID: 34865628 DOI: 10.1186/s12890-021-01775-1] [Reference Citation Analysis]
113 Blanchard C, Pattou F, Brunaud L, Hamy A, Dahan M, Mathonnet M, Volteau C, Caillard C, Durand-Zaleski I, Mirallié E; FOThyr Group. Randomized clinical trial of ultrasonic scissors versus conventional haemostasis to compare complications and economics after total thyroidectomy (FOThyr). BJS Open 2017;1:2-10. [PMID: 29951599 DOI: 10.1002/bjs5.2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
114 Su D, Wu B, Shi L. Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma. JAMA Netw Open 2021;4:e210037. [PMID: 33625508 DOI: 10.1001/jamanetworkopen.2021.0037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
115 Loperto I, Simonetti A, Nardone A, Triassi M. Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence. Hum Vaccin Immunother 2019;15:1035-47. [PMID: 30735465 DOI: 10.1080/21645515.2019.1578597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
116 Simpson KN, Simpson AN, Mauldin PD, Palesch YY, Yeatts SD, Kleindorfer D, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Broderick JP; Interventional Management of Stroke (IMS) III Investigators. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc 2017;6:e004513. [PMID: 28483774 DOI: 10.1161/JAHA.116.004513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
117 Barkun AN, Adam V, Lu Y, Chen YI, Martel M. Using Hemospray Improves the Cost-effectiveness Ratio in the Management of Upper Gastrointestinal Nonvariceal Bleeding. J Clin Gastroenterol 2018;52:36-44. [PMID: 27749635 DOI: 10.1097/MCG.0000000000000709] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
118 Hiligsmann M, Maggi S, Veronese N, Sartori L, Reginster JY. Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy. Osteoporos Int 2021;32:595-606. [PMID: 33443610 DOI: 10.1007/s00198-020-05802-5] [Reference Citation Analysis]
119 Antonio Buendía J, Patiño DG. Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia. Expert Rev Pharmacoecon Outcomes Res 2021;:1-6. [PMID: 34860616 DOI: 10.1080/14737167.2022.2011217] [Reference Citation Analysis]
120 Gordon LG, Eakin EG, Spence RR, Pyke C, Bashford J, Saunders C, Hayes SC. Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up. Int J Environ Res Public Health 2020;17:E8608. [PMID: 33228174 DOI: 10.3390/ijerph17228608] [Reference Citation Analysis]
121 Zhang S, King D, Rosen VM, Ismaila AS. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. Int J Chron Obstruct Pulmon Dis 2020;15:417-38. [PMID: 32161454 DOI: 10.2147/COPD.S234823] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
122 Uchida-Nakakoji M, Stone PW, Schmitt S, Phibbs C, Wang YC. Economic evaluation of registered nurse tenure on nursing home resident outcomes. Appl Nurs Res 2016;29:89-95. [PMID: 26856495 DOI: 10.1016/j.apnr.2015.05.001] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
123 Yi ZM, Qiu TT, Zhang Y, Liu N, Zhai SD. Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation. Ther Clin Risk Manag 2018;14:709-19. [PMID: 29713179 DOI: 10.2147/TCRM.S163190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
124 Dawoud DM, Wonderling D, Glen J, Lewis S, Griffin XL, Hunt BJ, Stansby G, Reed M, Rossiter N, Chahal JK, Sharpin C, Barry P. Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service. Front Pharmacol 2018;9:1370. [PMID: 30564117 DOI: 10.3389/fphar.2018.01370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
125 Gumbie M, Parkinson B, Cutler H, Gauld N, Mumford V. Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions. Pharmacoeconomics 2019;37:1049-64. [PMID: 31069781 DOI: 10.1007/s40273-019-00804-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
126 Mistry H, Connock M, Pink J, Shyangdan D, Clar C, Royle P, Court R, Biant LC, Metcalfe A, Waugh N. Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technol Assess 2017;21:1-294. [PMID: 28244303 DOI: 10.3310/hta21060] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 19.3] [Reference Citation Analysis]
127 Aksan A, Beales ILP, Baxter G, de Arellano AR, Gavata S, Valentine WJ, Hunt B. Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK. Clinicoecon Outcomes Res 2021;13:541-52. [PMID: 34168471 DOI: 10.2147/CEOR.S306823] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Le P, Nghiem VT, Mullen PD, Deshpande A. Cost-Effectiveness of Competing Treatment Strategies for Clostridium difficile Infection: A Systematic Review. Infect Control Hosp Epidemiol 2018;39:412-24. [PMID: 29463339 DOI: 10.1017/ice.2017.303] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
129 Gansen FM. Health economic evaluations based on routine data in Germany: a systematic review. BMC Health Serv Res 2018;18:268. [PMID: 29636046 DOI: 10.1186/s12913-018-3080-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
130 Pryymachenko Y, Wilson R, Sharma S, Pathak A, Abbott JH. Are manual therapy or booster sessions worthwhile in addition to exercise therapy for knee osteoarthritis: Economic evaluation and 2-year follow-up of a randomized controlled trial. Musculoskelet Sci Pract 2021;56:102439. [PMID: 34375855 DOI: 10.1016/j.msksp.2021.102439] [Reference Citation Analysis]
131 Wang X, Guo G, Zheng J, Lu L. Cost-effectiveness of option B+ in prevention of mother-to-child transmission of HIV in Yunnan Province, China. BMC Infect Dis 2019;19:517. [PMID: 31185927 DOI: 10.1186/s12879-019-3976-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
132 Chen CM, Yang YH, Lee M, Chen KH, Huang SS. Economic evaluation of transferring first-stroke survivors to rehabilitation wards: A 10-year longitudinal, population-based study. Top Stroke Rehabil 2020;27:8-14. [PMID: 31535585 DOI: 10.1080/10749357.2019.1642652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Kågesten A, Tunçalp Ӧ, Ali M, Chandra-Mouli V, Tran N, Gülmezoglu AM. A Systematic Review of Reporting Tools Applicable to Sexual and Reproductive Health Programmes: Step 1 in Developing Programme Reporting Standards. PLoS One 2015;10:e0138647. [PMID: 26418859 DOI: 10.1371/journal.pone.0138647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
134 Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Kluibenschaedl M, Conrads-Frank A, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Leuk Lymphoma 2015;56:2315-25. [PMID: 25393806 DOI: 10.3109/10428194.2014.982635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
135 Kienle GS, Ben-Arye E, Berger B, Cuadrado Nahum C, Falkenberg T, Kapócs G, Kiene H, Martin D, Wolf U, Szöke H. Contributing to Global Health: Development of a Consensus-Based Whole Systems Research Strategy for Anthroposophic Medicine. Evid Based Complement Alternat Med 2019;2019:3706143. [PMID: 31781267 DOI: 10.1155/2019/3706143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Lince-Deroche N, van Rensburg C, Roseleur J, Sanusi B, Phiri J, Michelow P, Smith JS, Firnhaber C. Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa. PLoS One 2018;13:e0203921. [PMID: 30308014 DOI: 10.1371/journal.pone.0203921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Callender T, Emberton M, Morris S, Eeles R, Kote-Jarai Z, Pharoah PDP, Pashayan N. Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study. PLoS Med 2019;16:e1002998. [PMID: 31860675 DOI: 10.1371/journal.pmed.1002998] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
138 Marcellusi A, Capone A, Favato G, Mennini FS, Baio G, Haeussler K, Bononi M. Health Utilities Lost and Risk Factors Associated With HPV-induced Diseases in Men and Women: The HPV Italian Collaborative Study Group. Clinical Therapeutics 2015;37:156-167.e4. [DOI: 10.1016/j.clinthera.2014.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
139 Leung HW, Lang HC, Wang SY, Leung JH, Chan AL. Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck. Expert Rev Pharmacoecon Outcomes Res 2021;21:489-95. [PMID: 33729079 DOI: 10.1080/14737167.2021.1890585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Chen K, Zhong Y, Gu Y, Sharma R, Li M, Zhou J, Wu Y, Gao Y, Qin G. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model. JAMA Netw Open 2020;3:e2023949. [PMID: 33275150 DOI: 10.1001/jamanetworkopen.2020.23949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
141 Steen Carlsson K, Andsberg G, Petersson J, Norrving B. Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke). International Journal of Stroke 2017;12:802-14. [DOI: 10.1177/1747493017701154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
142 Stella SF, Polanczyk CA, Arvandi M, Siebert U. Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil. Int J Qual Health Care 2019;31:676-81. [PMID: 30576452 DOI: 10.1093/intqhc/mzy240] [Reference Citation Analysis]
143 Zakiyah N, Sinuraya RK, Kusuma ASW, Suwantika AA, Lestari K. Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia. Clinicoecon Outcomes Res 2021;13:863-72. [PMID: 34675566 DOI: 10.2147/CEOR.S322740] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Labib ME, Hassanein OE, Moussa M, Yassen A, Schwendicke F. Selective versus stepwise removal of deep carious lesions in permanent teeth: a randomised controlled trial from Egypt-an interim analysis. BMJ Open 2019;9:e030957. [PMID: 31530615 DOI: 10.1136/bmjopen-2019-030957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
145 Ciani O, Epstein D, Rothery C, Taylor RS, Sculpher M. Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms. Cost Eff Resour Alloc 2018;16:15. [PMID: 29686541 DOI: 10.1186/s12962-018-0098-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Mariño R, Ravisankar G, Zaror C. Quality appraisal of economic evaluations done on oral health preventive programs-A systematic review. J Public Health Dent 2020;80:194-207. [PMID: 32311103 DOI: 10.1111/jphd.12368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
147 Sykes KJ, Scranton RA, Villarroel L, Anderson BV, Salek S, Stall J. Using Surveillance Data to Respond to an Outbreak of Congenital Syphilis in Arizona Through Third-Trimester Screening Policies, 2017-2018. Public Health Rep 2021;136:61-9. [PMID: 33211993 DOI: 10.1177/0033354920967350] [Reference Citation Analysis]
148 Simpson KN, Fossler MJ, Wase L, Demitrack MA. Cost-effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain. J Comp Eff Res 2021. [PMID: 34240625 DOI: 10.2217/cer-2021-0107] [Reference Citation Analysis]
149 Kromer C, Celis D, Sonntag D, Peitsch WK. Biologicals and small molecules in psoriasis: A systematic review of economic evaluations. PLoS One 2018;13:e0189765. [PMID: 29298315 DOI: 10.1371/journal.pone.0189765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
150 Griffin SO, Jones K. Quality of reporting in economic evaluations of interventions to prevent dental caries needs improvement. J Evid Based Dent Pract 2013;13:109-10. [PMID: 24011008 DOI: 10.1016/j.jebdp.2013.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
151 Schnippel K, Lince-Deroche N, van den Handel T, Molefi S, Bruce S, Firnhaber C. Cost evaluation of reproductive and primary health care mobile service delivery for women in two rural districts in South Africa. PLoS One 2015;10:e0119236. [PMID: 25751528 DOI: 10.1371/journal.pone.0119236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
152 Ramachandran J, Kaambwa B, Muller K, Haridy J, Tse E, Tilley E, Altus R, Waddell V, Gordon D, Shaw D, Huynh D, Stewart J, Nelson R, Warner M, Boyd MA, Chinnaratha MA, Harding D, Ralton L, Colman A, Woodman R, Wigg AJ. Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience. Eur J Gastroenterol Hepatol 2020;32:1381-9. [PMID: 31895911 DOI: 10.1097/MEG.0000000000001659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Oluyase AO, Higginson IJ, Yi D, Gao W, Evans CJ, Grande G, Todd C, Costantini M, Murtagh FE, Bajwah S. Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review. Health Serv Deliv Res 2021;9:1-218. [DOI: 10.3310/hsdr09120] [Reference Citation Analysis]
154 Marquina C, Lacaze P, Tiller J, Riaz M, Sturm AC, Nelson MR, Ference BA, Pang J, Watts GF, Nicholls SJ, Zoungas S, Liew D, McNeil J, Ademi Z. Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis. Eur Heart J 2021:ehab770. [PMID: 34788414 DOI: 10.1093/eurheartj/ehab770] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Hiligsmann M, Williams SA, Fitzpatrick LA, Silverman SS, Weiss R, Reginster J. Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fracture. Seminars in Arthritis and Rheumatism 2019;49:184-96. [DOI: 10.1016/j.semarthrit.2019.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
156 Shelmerdine SC, Arthurs OJ, Denniston A, Sebire NJ. Review of study reporting guidelines for clinical studies using artificial intelligence in healthcare. BMJ Health Care Inform 2021;28:e100385. [PMID: 34426417 DOI: 10.1136/bmjhci-2021-100385] [Reference Citation Analysis]
157 Cha S, Jung S, Bizuneh DB, Abera T, Doh YA, Seong J, Ross I. Benefits and Costs of a Community-Led Total Sanitation Intervention in Rural Ethiopia-A Trial-Based ex post Economic Evaluation. Int J Environ Res Public Health 2020;17:E5068. [PMID: 32674392 DOI: 10.3390/ijerph17145068] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Xie X, Wang M, Goh ES, Ungar WJ, Little J, Carroll JC, Okun N, Huang T, Rousseau F, Dougan SD, Tu HA, Higgins C, Holubowich C, Sikich N, Dhalla IA, Ng V. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis. J Obstet Gynaecol Can 2020;42:740-749.e12. [PMID: 32008974 DOI: 10.1016/j.jogc.2019.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Elliott J, van Katwyk S, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations. Pharmacoeconomics 2019;37:1261-76. [PMID: 31201643 DOI: 10.1007/s40273-019-00816-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
160 Kazi DS, Virani SS. Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside. Progress in Cardiovascular Diseases 2019;62:406-13. [DOI: 10.1016/j.pcad.2019.10.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Wang J, Phi XA, Greuter MJW, Daszczuk AM, Feenstra TL, Pijnappel RM, Vermeulen KM, Buls N, Houssami N, Lu W, de Bock GH. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program. Eur Radiol 2020;30:5437-45. [PMID: 32382844 DOI: 10.1007/s00330-020-06812-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Jiménez-ruiz CA, Martín V, Alsina-restoy X, Granda-orive JI, de Higes-martínez E, García-rueda M, Genovés-crespo M, López-garcía C, Lorza-blasco JJ, Márquez FL, Ramos-pinedo Á, Riesco-miranda JA, Signes-costa J, Solano-reina S, Vaquero-lozano P, Rejas J. Cost–benefit analysis of funding smoking cessation before surgery. British Journal of Surgery 2020;107:978-94. [DOI: 10.1002/bjs.11506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Castro R, Crathorne L, Perazzo H, Silva J, Cooper C, Varley-Campbell J, Marinho DS, Haasova M, Veloso VG, Anderson R, Hyde C. Cost-effectiveness of diagnostic and therapeutic interventions for chronic hepatitis C: a systematic review of model-based analyses. BMC Med Res Methodol 2018;18:53. [PMID: 29895281 DOI: 10.1186/s12874-018-0515-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
164 Wallace K, Adamski K, Pai A, Rose D, Chawla A. The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian Cancer. Pharmacoeconomics 2021;39:231-41. [PMID: 33145712 DOI: 10.1007/s40273-020-00970-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Tai BB, Bae YH, Le QA. A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective. Value in Health 2016;19:903-8. [DOI: 10.1016/j.jval.2016.05.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
166 Chorozoglou M, Reading I, Eaton S, Hutchings N, Hall NJ. Health economics and quality of life in a feasibility RCT of paediatric acute appendicitis: a protocol study. BMJ Paediatr Open 2018;2:e000347. [PMID: 30276343 DOI: 10.1136/bmjpo-2018-000347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
167 Alrajhi S, Barkun A, Adam V, Callichurn K, Martel M, Brewer O, Khashab MA, Forbes N, Almadi MA, Chen YI. Early cholangioscopy-assisted electrohydraulic lithotripsy in difficult biliary stones is cost-effective. Therap Adv Gastroenterol 2021;14:17562848211031388. [PMID: 34804204 DOI: 10.1177/17562848211031388] [Reference Citation Analysis]
168 Png ME, Yang M, Roberts N, Taylor-Phillips S, Rivero-Arias O, Petrou S. Methods for evaluating the benefits and harms of antenatal and newborn screening programmes adopted by health economic assessments: protocol for a systematic review. BMJ Open 2021;11:e048031. [PMID: 34429311 DOI: 10.1136/bmjopen-2020-048031] [Reference Citation Analysis]
169 van Puffelen E, Polinder S, Vanhorebeek I, Wouters PJ, Bossche N, Peers G, Verstraete S, Joosten KFM, Van den Berghe G, Verbruggen SCAT, Mesotten D. Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial. Crit Care 2018;22:4. [PMID: 29335014 DOI: 10.1186/s13054-017-1936-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
170 Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review. Vaccine 2014;32:1645-53. [PMID: 24534737 DOI: 10.1016/j.vaccine.2014.01.058] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
171 Penn CA, Wong MS, Walsh CS. Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States. JAMA Netw Open 2020;3:e2028620. [PMID: 33295974 DOI: 10.1001/jamanetworkopen.2020.28620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Meys EMJ, Jeelof LS, Ramaekers BLT, Dirksen CD, Kooreman LFS, Slangen BFM, Kruitwagen RFPM, Van Gorp T. Economic evaluation of an expert examiner and different ultrasound models in the diagnosis of ovarian cancer. Eur J Cancer 2018;100:55-64. [PMID: 29957561 DOI: 10.1016/j.ejca.2018.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
173 Obermair A, Nicklin J, Gebski V, Hayes SC, Graves N, Mileshkin L, Lin MY, Beale P, Baxter E, Robledo K, Salomon C, Hanna GB, Janda M. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020. Int J Gynecol Cancer 2021:ijgc-2021-003029. [PMID: 34728527 DOI: 10.1136/ijgc-2021-003029] [Reference Citation Analysis]
174 Soliman R, Elhaddad A, Oke J, Eweida W, Tarek N, Hamza M, Yang Y, Abouelnaga S, Heneghan C. Childhood cancer hospital resource utilization and costs in Egypt, 2013-2017; patterns, trends, and associated factors for 8886 patients from Children's Cancer Hospital, Egypt. Pediatr Blood Cancer 2021;68:e29347. [PMID: 34520099 DOI: 10.1002/pbc.29347] [Reference Citation Analysis]
175 Aranda-Reneo I, Rodríguez-Sánchez B, Peña-Longobardo LM, Oliva-Moreno J, López-Bastida J. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis. Value Health 2021;24:431-42. [PMID: 33641778 DOI: 10.1016/j.jval.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
176 Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL. Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma. JCO 2017;35:63-71. [DOI: 10.1200/jco.2016.68.4308] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 8.8] [Reference Citation Analysis]
177 Villemoes MK, Lindholt JS, Houlind KC, Gottschalksen B, Petersen CN, Rasmussen M, Wedel C, Bramsen MB, Søgaard R. Cost-Effectiveness Evaluation of Heparin Coated Versus Standard Graft for Bypass Surgery in Peripheral Artery Disease Alongside a Randomised Controlled Trial. Eur J Vasc Endovasc Surg 2018;56:87-93. [PMID: 29622512 DOI: 10.1016/j.ejvs.2018.03.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
178 Javaud N, Bouillet L, Rabetrano H, Bitoun A, Launay D, Lapostolle F, Reuter PG, Martin L, Vicaut E, Fain O, Adnet F, Durand-Zaleski I; SOS-HAE Collaborative Study Group. Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients. J Allergy Clin Immunol Pract 2019;7:328-30. [PMID: 29936190 DOI: 10.1016/j.jaip.2018.05.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
179 Giménez E, García-pérez L, Márquez S, Gutiérrez MA, Bayón JC, Espallargues M. Once años de evaluaciones económicas de productos sanitarios en la Red de Agencias de Evaluación. Calidad metodológica e impacto del coste-utilidad. Gaceta Sanitaria 2020;34:326-33. [DOI: 10.1016/j.gaceta.2019.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
180 Poder TG, Kouakou CRC, Bouchard PA, Tremblay V, Blais S, Maltais F, Lellouche F. Cost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec. BMJ Open 2018;8:e018835. [PMID: 29362258 DOI: 10.1136/bmjopen-2017-018835] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
181 Javaud N, Fain O, Durand-Zaleski I, Launay D, Bouillet L, Gompel A, Sobel A, Woimant M, Rabetrano H, Petrovic T, Lapostolle F, Boccon-Gibod I, Reuter PG, Bertrand P, Mezaour M, Coppere B, Floccard B, Kanny G, Baker E, Martin L, Vicaut E, Adnet F. Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial. Ann Emerg Med 2018;72:194-203.e1. [PMID: 29503044 DOI: 10.1016/j.annemergmed.2018.01.053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
182 Pulkki-Brännström AM, Haghparast-Bidgoli H, Batura N, Colbourn T, Azad K, Banda F, Banda L, Borghi J, Fottrell E, Kim S, Makwenda C, Ojha AK, Prost A, Rosato M, Shaha SK, Sinha R, Costello A, Skordis J. Participatory learning and action cycles with women's groups to prevent neonatal death in low-resource settings: A multi-country comparison of cost-effectiveness and affordability. Health Policy Plan 2021;35:1280-9. [PMID: 33085753 DOI: 10.1093/heapol/czaa081] [Reference Citation Analysis]
183 Marques EM, Blom AW, Lenguerrand E, Wylde V, Noble SM. Local anaesthetic wound infiltration in addition to standard anaesthetic regimen in total hip and knee replacement: long-term cost-effectiveness analyses alongside the APEX randomised controlled trials. BMC Med 2015;13:151. [PMID: 26116078 DOI: 10.1186/s12916-015-0389-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
184 McCreanor V, Graves N, Barnett AG, Parsonage W, Merlo G. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment. F1000Res 2018;7:77. [PMID: 30026922 DOI: 10.12688/f1000research.13616.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
185 Franklin M, Wailoo A, Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. The Cost-Effectiveness of Antibiotic Prophylaxis for Patients at Risk of Infective Endocarditis. Circulation 2016;134:1568-78. [PMID: 27840334 DOI: 10.1161/CIRCULATIONAHA.116.022047] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 6.6] [Reference Citation Analysis]
186 Groessl EJ, Liu L, Richard EL, Tally SR. Cost-effectiveness of Yoga for Chronic Low Back Pain in Veterans. Med Care 2020;58 Suppl 2 9S:S142-8. [PMID: 32826784 DOI: 10.1097/MLR.0000000000001356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Bailey SL, Bono RS, Nash D, Kimmel AD. Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections. PLoS One 2018;13:e0194916. [PMID: 29570737 DOI: 10.1371/journal.pone.0194916] [Reference Citation Analysis]
188 Rezapour A, Souresrafil A, Peighambari MM, Heidarali M, Tashakori-Miyanroudi M. Economic evaluation of programs against COVID-19: A systematic review. Int J Surg 2021;85:10-8. [PMID: 33227532 DOI: 10.1016/j.ijsu.2020.11.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
189 García-Pérez L, Linertová R, Arvelo-Martín A, Guerra-Marrero C, Martínez-Alberto CE, Cuéllar-Pompa L, Escobar A, Serrano-Aguilar P. METHODOLOGICAL QUALITY OF ECONOMIC EVALUATIONS ALONGSIDE TRIALS OF KNEE PHYSIOTHERAPY. Int J Technol Assess Health Care 2017;33:454-62. [PMID: 28857017 DOI: 10.1017/S0266462317000757] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
190 Assis TM, Rabello A, Cota G. Economic evaluations addressing diagnosis and treatment strategies for neglected tropical diseases: an overview. Rev Inst Med Trop Sao Paulo 2021;63:e41. [PMID: 34037157 DOI: 10.1590/S1678-9946202163041] [Reference Citation Analysis]
191 Bayón JC, Orruño E, Portillo MI, Asua J. The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis. Cost Eff Resour Alloc 2019;17:6. [PMID: 30867656 DOI: 10.1186/s12962-019-0173-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
192 El Alili M, van Dongen JM, Huirne JAF, van Tulder MW, Bosmans JE. Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology. Pharmacoeconomics 2017;35:1007-33. [PMID: 28674846 DOI: 10.1007/s40273-017-0531-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
193 Jódar-Sánchez F, Carrasco Hernández L, Núñez-Benjumea FJ, Mesa González MA, Moreno Conde J, Parra Calderón CL, Fernandez-Luque L, Hors-Fraile S, Civit A, Bamidis P, Ortega-Ruiz F. Using the Social-Local-Mobile App for Smoking Cessation in the SmokeFreeBrain Project: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2018;7:e12464. [PMID: 30522992 DOI: 10.2196/12464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
194 Mariño RJ, Khan AR, Morgan M. Systematic review of publications on economic evaluations of caries prevention programs. Caries Res 2013;47:265-72. [PMID: 23407213 DOI: 10.1159/000346917] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
195 Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A. A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis. Pharmacoeconomics 2015;33:205-24. [PMID: 25377850 DOI: 10.1007/s40273-014-0231-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
196 Schouten MJE, Dekker JJM, de Bruijn TQ, Ebert DD, Koomen LM, Kosterman SLA, Riper H, Schaub MP, Goudriaan AE, Blankers M. Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: study protocol of a multicentre pragmatic randomized controlled trial. BMC Psychiatry 2021;21:265. [PMID: 34022840 DOI: 10.1186/s12888-021-03222-1] [Reference Citation Analysis]
197 Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O'Grady M, Huang ES. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Med Decis Making 2018;38:942-53. [PMID: 30403576 DOI: 10.1177/0272989X18803109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
198 Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KA. HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr 2014;67 Suppl 1:S87-95. [PMID: 25117965 DOI: 10.1097/QAI.0000000000000254] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
199 Ding H, Xin W, Tong Y, Sun J, Xu G, Ye Z, Rao Y. Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review. PLoS One 2020;15:e0238536. [PMID: 32877435 DOI: 10.1371/journal.pone.0238536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
200 Smit GS, Apers L, Arrazola de Onate W, Beutels P, Dorny P, Forier AM, Janssens K, Macq J, Mak R, Schol S, Wildemeersch D, Speybroeck N, Devleesschauwer B. Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium. Bull World Health Organ 2017;95:27-35. [PMID: 28053362 DOI: 10.2471/BLT.16.169383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
201 Buendía JA, Guerrero Patiño D, Talamoni HL. Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma. Pediatr Pulmonol 2021. [PMID: 34473917 DOI: 10.1002/ppul.25645] [Reference Citation Analysis]
202 Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada) 2021;19:2302. [PMID: 33727994 DOI: 10.18549/PharmPract.2021.1.2302] [Reference Citation Analysis]
203 Boland MR, Kruis AL, Tsiachristas A, Assendelft WJ, Gussekloo J, Blom CM, Chavannes NH, Rutten-van Mölken MP. Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial. BMJ Open 2015;5:e007284. [PMID: 26525419 DOI: 10.1136/bmjopen-2014-007284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
204 Kip MMA, Currie G, Marshall DA, Grazziotin Lago L, Twilt M, Vastert SJ, Swart JF, Wulffraat N, Yeung RSM, Benseler SM, IJzerman MJ; UCAN CAN-DU Health Economics Working Group. Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review. Pediatr Rheumatol Online J 2019;17:20. [PMID: 31060557 DOI: 10.1186/s12969-019-0321-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
205 Zaror C, Muñoz-millán P, Espinoza-espinoza G, Vergara-gonzález C, Martínez-zapata MJ. Cost-effectiveness of adding fluoride varnish to a preventive protocol for early childhood caries in rural children with no access to fluoridated drinking water. Journal of Dentistry 2020;98:103374. [DOI: 10.1016/j.jdent.2020.103374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
206 Wong A, Goh G, Banks MD, Bauer JD. A systematic review of the cost and economic outcomes of home enteral nutrition. Clin Nutr 2018;37:429-42. [PMID: 28679469 DOI: 10.1016/j.clnu.2017.06.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
207 Hiligsmann M, Reginster JY. Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France. Osteoporos Int 2019;30:649-58. [PMID: 30701342 DOI: 10.1007/s00198-018-04821-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
208 Chaudhary RK, Philip MJ, Santhosh A, Karoli SS, Bhandari R, Ganachari MS. Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy. Diabetes Metab Syndr 2021;15:102303. [PMID: 34626923 DOI: 10.1016/j.dsx.2021.102303] [Reference Citation Analysis]
209 Gorham G, Howard K, Togni S, Lawton P, Hughes J, Majoni SW, Brown S, Barnes S, Cass A. Economic and quality of care evaluation of dialysis service models in remote Australia: protocol for a mixed methods study. BMC Health Serv Res 2017;17:320. [PMID: 28468619 DOI: 10.1186/s12913-017-2273-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
210 Peng K, Yang M, Tian M, Chen M, Zhang J, Wu X, Ivers R, Si L. Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing. Osteoporos Int 2020;31:1545-53. [PMID: 32219498 DOI: 10.1007/s00198-020-05393-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 van Giessen A, Peters J, Wilcher B, Hyde C, Moons C, de Wit A, Koffijberg E. Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating. Value Health 2017;20:718-26. [PMID: 28408017 DOI: 10.1016/j.jval.2017.01.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
212 Isaza N, Calvachi P, Raber I, Liu CL, Bellows BK, Hernandez I, Shen C, Gavin MC, Garan AR, Kazi DS. Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction. JAMA Netw Open 2021;4:e2114501. [PMID: 34313742 DOI: 10.1001/jamanetworkopen.2021.14501] [Reference Citation Analysis]
213 Mitchell BG, Fasugba O, Cheng AC, Gregory V, Koerner J, Collignon P, Gardner A, Graves N. Chlorhexidine versus saline in reducing the risk of catheter associated urinary tract infection: A cost-effectiveness analysis. Int J Nurs Stud 2019;97:1-6. [PMID: 31129443 DOI: 10.1016/j.ijnurstu.2019.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
214 Karasawa Y, Kamae I, Nozawa K, Zeniya S, Murata T, Soen S, Sakamoto C. Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan. PLoS One 2021;16:e0253547. [PMID: 34228745 DOI: 10.1371/journal.pone.0253547] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Doble B. Comment on: systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity. Surg Obes Relat Dis 2018;14:1059-61. [PMID: 29703504 DOI: 10.1016/j.soard.2018.03.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Drolet M, Bénard É, Jit M, Hutubessy R, Brisson M. Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value Health 2018;21:1250-8. [PMID: 30314627 DOI: 10.1016/j.jval.2018.03.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
217 Iribarren SJ, Cato K, Falzon L, Stone PW. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PLoS One 2017;12:e0170581. [PMID: 28152012 DOI: 10.1371/journal.pone.0170581] [Cited by in Crossref: 192] [Cited by in F6Publishing: 153] [Article Influence: 38.4] [Reference Citation Analysis]
218 Fontenay S, Catarino L, Snoussi S, van den Brink H, Pineau J, Prognon P, Martelli N. Quality of economic evaluations of ventricular assist devices: A systematic review. Int J Technol Assess Health Care 2020;:1-8. [PMID: 32618521 DOI: 10.1017/S0266462320000409] [Reference Citation Analysis]
219 Ninomiya K, Saito T, Okochi T, Taniguchi S, Shimasaki A, Aoki R, Hata T, Mushiroda T, Kanazawa T, Ikeda M, Iwata N. Cost effectiveness of pharmacogenetic-guided clozapine administration based on risk of HLA variants in Japan and the UK. Transl Psychiatry 2021;11:362. [PMID: 34230449 DOI: 10.1038/s41398-021-01487-4] [Reference Citation Analysis]
220 Haldar S, Khan HR, Boyalla V, Kralj-hans I, Jones S, Lord J, Onyimadu O, Sathishkumar A, Bahrami T, Clague J, De Souza A, Francis D, Hussain W, Jarman J, Jones DG, Chen Z, Mediratta N, Hyde J, Lewis M, Mohiaddin R, Salukhe T, Murphy C, Kelly J, Khattar R, Toff WD, Markides V, Mccready J, Gupta D, Wong T. Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT. Efficacy Mech Eval 2021;8:1-122. [DOI: 10.3310/eme08180] [Reference Citation Analysis]
221 Elliott J, McCoy B, Clifford T, Potter BK, Skidmore B, Wells GA, Coyle D. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations. Syst Rev 2019;8:75. [PMID: 30917869 DOI: 10.1186/s13643-019-0990-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
222 Si L, Eisman JA, Winzenberg T, Sanders KM, Center JR, Nguyen TV, Tran T, Palmer AJ. Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis. Osteoporos Int 2021. [PMID: 33856500 DOI: 10.1007/s00198-021-05955-x] [Reference Citation Analysis]
223 Buendia JA, Guerrero Patiño D, Cossio-Giraldo YE. Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma. J Asthma 2021;:1-8. [PMID: 34551659 DOI: 10.1080/02770903.2021.1984527] [Reference Citation Analysis]
224 Cernat A, Jamieson M, Kavelaars R, Khalili S, Bhambhwani V, Mireskandari K, Moretti ME. Immediate versus delayed sequential bilateral cataract surgery in children: a cost-effectiveness analysis. Br J Ophthalmol 2020:bjophthalmol-2020-316507. [PMID: 33218991 DOI: 10.1136/bjophthalmol-2020-316507] [Reference Citation Analysis]
225 Cheng Q, Gibb M, Graves N, Finlayson K, Pacella RE. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia. BMC Health Serv Res 2018;18:421. [PMID: 29880046 DOI: 10.1186/s12913-018-3234-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
226 Wang X, Penm J, Patanwala AE. Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries. Curr Med Res Opin 2021;:1-7. [PMID: 34641744 DOI: 10.1080/03007995.2021.1993161] [Reference Citation Analysis]
227 Duchesne L, Hejblum G, Toure Kane NC, Njouom R, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal. Int J Drug Policy 2020;75:102613. [PMID: 31786434 DOI: 10.1016/j.drugpo.2019.102613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
228 Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend 2014;145:48-68. [PMID: 25456324 DOI: 10.1016/j.drugalcdep.2014.10.012] [Cited by in Crossref: 216] [Cited by in F6Publishing: 195] [Article Influence: 27.0] [Reference Citation Analysis]
229 Watson TR, Gao X, Reynolds KL, Kong CY. Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US. JAMA Netw Open 2020;3:e2016144. [PMID: 33052401 DOI: 10.1001/jamanetworkopen.2020.16144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
230 Hogendoorn W, Moll FL, Sumpio BE, Hunink MM. Clinical Decision Analysis and Markov Modeling for Surgeons: An Introductory Overview. Annals of Surgery 2016;264:268-74. [DOI: 10.1097/sla.0000000000001569] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
231 Choi H, Mohit B. Cost‐effectiveness of screening for HLA‐B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. Epilepsia 2019;60:1472-81. [DOI: 10.1111/epi.16053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
232 Chen YI, Khashab MA, Adam V, Bai G, Singh VK, Bukhari M, Brewer Gutierrez O, Elmunzer BJ, Moran RA, Fayad L, El Zein M, Kumbhari V, Repici A, Barkun AN. Plastic stents are more cost-effective than lumen-apposing metal stents in management of pancreatic pseudocysts. Endosc Int Open. 2018;6:E780-E788. [PMID: 29977994 DOI: 10.1055/a-0611-5082] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
233 Marsden J, Pavlou M, Dennett R, Gibbon A, Knight-Lozano R, Jeu L, Flavell C, Freeman J, Bamiou DE, Harris C, Hawton A, Goodwin E, Jones B, Creanor S. Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo. BMC Neurol 2020;20:430. [PMID: 33243182 DOI: 10.1186/s12883-020-01983-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Gourzoulidis G, Kourlaba G, Kakisis J, Matsagkas M, Giannakoulas G, Gourgoulianis KI, Vassilakopoulos T, Maniadakis N. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece. Clin Drug Investig 2017;37:833-44. [PMID: 28608312 DOI: 10.1007/s40261-017-0540-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
235 Nymark LS, Miller A, Vassall A. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses. Pharmacoecon Open 2021. [PMID: 33948928 DOI: 10.1007/s41669-021-00269-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Moayeri F, Dunt D, Hsueh YA, Doyle C. Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. Expert Rev Pharmacoecon Outcomes Res 2019;19:331-40. [PMID: 30324818 DOI: 10.1080/14737167.2019.1536550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
237 Cipriano LE, Zaric GS. Cost-effectiveness of naloxone kits in secondary schools. Drug Alcohol Depend 2018;192:352-61. [PMID: 30321745 DOI: 10.1016/j.drugalcdep.2018.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
238 Marcos-Marcos J, Olry de Labry-Lima A, Toro-Cardenas S, Lacasaña M, Degroote S, Ridde V, Bermudez-Tamayo C. Impact, economic evaluation, and sustainability of integrated vector management in urban settings to prevent vector-borne diseases: a scoping review. Infect Dis Poverty 2018;7:83. [PMID: 30173675 DOI: 10.1186/s40249-018-0464-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
239 Ni W, Kunz WG, Goyal M, Chen L, Jiang Y. Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China. Health Econ Rev 2022;12:4. [PMID: 34993675 DOI: 10.1186/s13561-021-00352-w] [Reference Citation Analysis]
240 Pollock RF, Colaone F, Shergill S, Brennan VK, Agirrezabal I. Effects of Trial Population Selection on Quality of Life and Healthcare Decision-Making: A Systematic Review and Example in the Treatment of Hepatocellular Carcinoma with Radioembolization. Clinicoecon Outcomes Res 2021;13:835-41. [PMID: 34588788 DOI: 10.2147/CEOR.S319857] [Reference Citation Analysis]
241 Pitt C, Tawiah T, Soremekun S, ten Asbroek AH, Manu A, Tawiah-Agyemang C, Hill Z, Owusu-Agyei S, Kirkwood BR, Hanson K. Cost and cost-effectiveness of newborn home visits: findings from the Newhints cluster-randomised controlled trial in rural Ghana. Lancet Glob Health 2016;4:e45-56. [PMID: 26639857 DOI: 10.1016/S2214-109X(15)00207-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
242 Sicras-Mainar A, Sánchez-Álvarez L, Navarro-Artieda R, Darbà J. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis. Lipids Health Dis 2018;17:277. [PMID: 30522491 DOI: 10.1186/s12944-018-0918-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
243 Cotton CC, Erim D, Eluri S, Palmer SH, Green DJ, Wolf WA, Runge TM, Wheeler S, Shaheen NJ, Dellon ES. Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2017;15:841-849.e1. [PMID: 27940272 DOI: 10.1016/j.cgh.2016.11.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
244 Panagiotoglou D, Abrahamowicz M, Buckeridge DL, Caro JJ, Latimer E, Maheu-Giroux M, Strumpf EC. Evaluating Montréal's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis. BMJ Open 2021;11:e053191. [PMID: 34702731 DOI: 10.1136/bmjopen-2021-053191] [Reference Citation Analysis]
245 Boujaoude MA, Mirelman AJ, Dalziel K, Carvalho N. Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries. Cost Eff Resour Alloc 2018;16:18. [PMID: 29796012 DOI: 10.1186/s12962-018-0102-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
246 Halliday A, Jain P, Hoang L, Parker R, Tolosa-wright M, Masonou T, Green N, Boakye A, Takwoingi Y, Hamilton S, Mandagere V, Fries A, Coin L, Deeks J, White PJ, Levin M, Beverley P, Kon OM, Lalvani A. New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study. Efficacy Mech Eval 2021;8:1-160. [DOI: 10.3310/eme08050] [Reference Citation Analysis]
247 Huang D, Frank SJ, Verma V, Thaker NG, Brooks ED, Palmer MB, Harrison RF, Deshmukh AA, Ning MS. Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date. Int J Part Ther 2021;8:339-53. [PMID: 34285960 DOI: 10.14338/IJPT-20-00058.1] [Reference Citation Analysis]
248 van Mastrigt GA, Hiligsmann M, Arts JJ, Broos PH, Kleijnen J, Evers SM, Majoie MH. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Rev Pharmacoecon Outcomes Res 2016;16:689-704. [PMID: 27805469 DOI: 10.1080/14737167.2016.1246960] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 10.3] [Reference Citation Analysis]
249 Mattli R, Farcher R, Syleouni ME, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations. Sports Med 2020;50:731-50. [PMID: 31755043 DOI: 10.1007/s40279-019-01233-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
250 Wan W, Skandari MR, Minc A, Nathan AG, Winn A, Zarei P, O'Grady M, Huang ES. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care 2018;41:1227-34. [PMID: 29650803 DOI: 10.2337/dc17-1821] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
251 Vossen RJ, Philipszoon PC, Vahl AC, Montauban van Swijndregt AD, Leijdekkers VJ, Balm R. A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions. J Endovasc Ther 2019;26:172-80. [DOI: 10.1177/1526602819833646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
252 Aarts GWA, Camaro C, van Geuns RJ, Cramer E, van Kimmenade RRJ, Damman P, van Grunsven PM, Adang E, Giesen P, Rutten M, Ouwendijk O, Gomes MER, van Royen N. Acute rule-out of non-ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial. BMJ Open 2020;10:e034403. [PMID: 32071186 DOI: 10.1136/bmjopen-2019-034403] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
253 Lee PB, Hojjat H, Lucas J, Chung MT, Spillinger A, Meleca JB, Svider P, Shkoukani M, Johnson A, Folbe A. Cost-Effectiveness of Open vs. Endoscopic Repair of Zenker's Diverticulum. Ann Otol Rhinol Laryngol 2021;:34894211028507. [PMID: 34192947 DOI: 10.1177/00034894211028507] [Reference Citation Analysis]
254 Elliott J, McCoy B, Clifford T, Potter BK, Wells GA, Coyle D. Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis. Pharmacoeconomics 2020;38:971-80. [PMID: 32406036 DOI: 10.1007/s40273-020-00923-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
255 Wan W, Nathan AG, Skandari MR, Zarei P, Reid MW, Raymond JK, Huang ES. Cost-effectiveness of Shared Telemedicine Appointments in Young Adults With T1D: CoYoT1 Trial. Diabetes Care 2019;42:1589-92. [PMID: 31189564 DOI: 10.2337/dc19-0363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
256 Howell M, Walker RC, Howard K. Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations. Appl Health Econ Health Policy 2019;17:315-30. [PMID: 30714086 DOI: 10.1007/s40258-018-00455-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
257 Listl S, Weyant R. For careful consideration: the reporting of health economic evaluations in dentistry. J Public Health Dent 2019;79:273-4. [DOI: 10.1111/jphd.12344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
258 Patikorn C, Leelavanich D, Ismail AK, Othman I, Taychakhoonavudh S, Chaiyakunapruk N. Global systematic review of cost of illness and economic evaluation studies associated with snakebite. J Glob Health 2020;10:020415. [PMID: 33312499 DOI: 10.7189/jogh.10.020415] [Reference Citation Analysis]
259 Cronin P, Rawson JV, Heilbrun ME, Lee JM, Kelly AM, Sanelli PC, Bresnahan BW, Paladin AM. How to critically appraise the clinical literature. Acad Radiol 2014;21:1117-28. [PMID: 25107864 DOI: 10.1016/j.acra.2014.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
260 Santos J, Palumbo F, Molsen-david E, Willke RJ, Binder L, Drummond M, Ho A, Marder WD, Parmenter L, Sandhu G, Shafie AA, Thompson D. ISPOR Code of Ethics 2017 (4th Edition). Value in Health 2017;20:1227-42. [DOI: 10.1016/j.jval.2017.10.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
261 Rustgi VK, Duff SB, Elsaid MI. Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease. J Med Econ 2022;:1-29. [PMID: 35034553 DOI: 10.1080/13696998.2022.2026702] [Reference Citation Analysis]
262 Vicente E, Núñez‐alfonsel J, Ielpo B, Ferri V, Caruso R, Duran H, Diaz E, Malave L, Fabra I, Pinna E, Isernia R, Hidalgo A, Quijano Y. A cost‐effectiveness analysis of robotic versus laparoscopic distal pancreatectomy. Int J Med Robot 2020;16. [DOI: 10.1002/rcs.2080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
263 Rogers AJ, Rogers NG, Kilgore ML, Subramaniam A, Harper LM. Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery: A Systematic Review. Value Health 2017;20:163-73. [PMID: 28212958 DOI: 10.1016/j.jval.2016.08.738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
264 Mahalingam M, Peterson C, Bergen G. Systematic review of unintentional injury prevention economic evaluations 2010-2019 and comparison to 1998-2009. Accid Anal Prev 2020;146:105688. [PMID: 32911130 DOI: 10.1016/j.aap.2020.105688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
265 Ito K. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls. JAMA Netw Open 2020;3:e2027584. [PMID: 33258906 DOI: 10.1001/jamanetworkopen.2020.27584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
266 Posso M, Puig T, Carles M, Rué M, Canelo-Aybar C, Bonfill X. Effectiveness and cost-effectiveness of double reading in digital mammography screening: A systematic review and meta-analysis. Eur J Radiol 2017;96:40-9. [PMID: 29103474 DOI: 10.1016/j.ejrad.2017.09.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
267 Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis. Appl Health Econ Health Policy 2018;16:43-54. [PMID: 28980217 DOI: 10.1007/s40258-017-0352-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
268 Padula WV, McQueen RB, Pronovost PJ. Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine. Med Care 2017;55:915-7. [PMID: 29028755 DOI: 10.1097/MLR.0000000000000813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
269 Patanwala AE, Narayan SW, Haas CE, Abraham I, Sanders A, Erstad BL. Proposed guidance on cost-avoidance studies in pharmacy practice. Am J Health Syst Pharm 2021:zxab211. [PMID: 34007979 DOI: 10.1093/ajhp/zxab211] [Reference Citation Analysis]
270 Cronin P, Rawson JV, Heilbrun ME, Lee JM, Kelly AM, Sanelli PC, Bresnahan BW, Paladin AM. How to Report a Research Study. Academic Radiology 2014;21:1088-116. [DOI: 10.1016/j.acra.2014.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
271 Lince-Deroche N, Phiri J, Michelow P, Smith JS, Firnhaber C. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa. PLoS One 2015;10:e0141969. [PMID: 26569487 DOI: 10.1371/journal.pone.0141969] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
272 Fekadu G, Yao J, You JHS. A systematic review of pharmacoeconomic evaluations on oral diarylquinoline-based treatment for drug-resistant tuberculosis: from high to low burden countries. Expert Rev Pharmacoecon Outcomes Res 2021;:1-14. [PMID: 33931005 DOI: 10.1080/14737167.2021.1925111] [Reference Citation Analysis]
273 de Waal MM, Blankers M, Lommerse NM, Kikkert MJ, Dekker JJM, Goudriaan AE. Economic Evaluation of the SOS Training to Reduce Victimization in Dual Diagnosis Patients. J Dual Diagn 2021;17:333-43. [PMID: 34569438 DOI: 10.1080/15504263.2021.1965409] [Reference Citation Analysis]
274 Sullivan PW, Li Q, Bilir SP, Dang J, Kavati A, Yang M, Rajput Y. Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States. Curr Med Res Opin 2020;36:23-32. [PMID: 31491337 DOI: 10.1080/03007995.2019.1660539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
275 Feenstra T, Corro-Ramos I, Hamerlijnck D, van Voorn G, Ghabri S. Four Aspects Affecting Health Economic Decision Models and Their Validation. Pharmacoeconomics 2021. [PMID: 34913142 DOI: 10.1007/s40273-021-01110-w] [Reference Citation Analysis]
276 Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team. Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa. Clin Infect Dis 2019;69:588-95. [PMID: 30863852 DOI: 10.1093/cid/ciy971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
277 Radcliff TA, Côté MJ, Whittington MD, Daniels MJ, Bobroff LB, Janicke DM, Perri MG. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas. J Acad Nutr Diet 2020;120:1163-71. [PMID: 31899170 DOI: 10.1016/j.jand.2019.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Kahn JM. The Utility of Cost-Utility Analyses in Critical Care. Crit Care Med 2021;49:702-4. [PMID: 33731608 DOI: 10.1097/CCM.0000000000004859] [Reference Citation Analysis]
279 Te Ao B, Harwood M, Fu V, Weatherall M, McPherson K, Taylor WJ, McRae A, Thomson T, Gommans J, Green G, Ranta A, Hanger C, Riley J, McNaughton H. Economic analysis of the 'Take Charge' intervention for people following stroke: Results from a randomised trial. Clin Rehabil 2021;:2692155211040727. [PMID: 34414801 DOI: 10.1177/02692155211040727] [Reference Citation Analysis]
280 Xia Q, Campbell JA, Ahmad H, de Graaff B, Si L, Otahal P, Ratcliffe K, Turtle J, Marrone J, Huque M, Hagan B, Green M, Palmer AJ. Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system. Eur J Health Econ 2021. [PMID: 34767114 DOI: 10.1007/s10198-021-01405-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Gedge LM, Bettis AA, Bradley MH, Hollingsworth TD, Turner HC. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs. Parasit Vectors 2018;11:75. [PMID: 29391042 DOI: 10.1186/s13071-018-2616-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
282 Koffijberg H, Rothery C, Chalkidou K, Grutters J. Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations. Med Decis Making 2018;38:888-900. [DOI: 10.1177/0272989x18797948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
283 Tollens F, Baltzer PAT, Dietzel M, Schnitzer ML, Kunz WG, Rink J, Rübenthaler J, Froelich MF, Kaiser CG. Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening. Front Oncol 2021;11:724543. [PMID: 34568052 DOI: 10.3389/fonc.2021.724543] [Reference Citation Analysis]
284 Yi ZM, -, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD. Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles. Neuropsychiatr Dis Treat 2019;15:1-19. [PMID: 30587993 DOI: 10.2147/NDT.S181886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Lertjanyakun V, Chaiyakunapruk N, Kunisawa S, Imanaka Y. Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Metastatic Breast Cancer in Japan. Pharmacoeconomics 2018;36:1113-24. [PMID: 29707743 DOI: 10.1007/s40273-018-0660-3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
286 Takwoingi Y, Whitworth H, Rees-Roberts M, Badhan A, Partlett C, Green N, Boakye A, Lambie H, Marongiu L, Jit M, White P, Deeks JJ, Kon OM, Lalvani A. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation. Health Technol Assess 2019;23:1-152. [PMID: 31138395 DOI: 10.3310/hta23230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
287 Chiang CL, Chan SK, Lee SF, Wong IO, Choi HC. Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma. JAMA Netw Open 2021;4:e2033761. [PMID: 33464318 DOI: 10.1001/jamanetworkopen.2020.33761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
288 Rejas-Gutierrez J, Sicras-Mainar A, Darbà J. Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain. Ther Adv Musculoskelet Dis 2021;13:1759720X211010599. [PMID: 33995603 DOI: 10.1177/1759720X211010599] [Reference Citation Analysis]
289 Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res 2020;7:7. [PMID: 32111253 DOI: 10.1186/s40779-020-00238-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 75] [Article Influence: 26.0] [Reference Citation Analysis]
290 Cumming D, Song F, Taylor RS, Zahra M, Williams A, Eggington S. Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom. J Med Econ 2022;25:59-65. [PMID: 34890287 DOI: 10.1080/13696998.2021.2017200] [Reference Citation Analysis]
291 De la Plaza Llamas R, Ramia JM. Cost of postoperative complications: How to avoid calculation errors. World J Gastroenterol 2020; 26(21): 2682-2690 [PMID: 32550746 DOI: 10.3748/wjg.v26.i21.2682] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Elliott J, McCoy B, Clifford T, Wells GA, Coyle D. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis. Pharmacoeconomics 2018;36:1253-61. [PMID: 29761351 DOI: 10.1007/s40273-018-0669-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]